|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2002-3-27
|
|
pubmed:abstractText |
Recent evidence indicates that peroxisome proliferator-activated receptor-gamma (PPARgamma) is expressed at high levels in foam cells of atherosclerotic lesions, that PPARgamma agonists may directly modulate vessel wall function and that mutations in the PPARgamma-2 gene are associated with a reduced risk of coronary artery disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0804-4643
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
146
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
545-51
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:11916624-Adult,
pubmed-meshheading:11916624-Aged,
pubmed-meshheading:11916624-Aged, 80 and over,
pubmed-meshheading:11916624-Coronary Disease,
pubmed-meshheading:11916624-Diabetes Mellitus, Type 2,
pubmed-meshheading:11916624-Diabetic Angiopathies,
pubmed-meshheading:11916624-Female,
pubmed-meshheading:11916624-Genetic Predisposition to Disease,
pubmed-meshheading:11916624-Genetic Variation,
pubmed-meshheading:11916624-Humans,
pubmed-meshheading:11916624-Male,
pubmed-meshheading:11916624-Middle Aged,
pubmed-meshheading:11916624-Prospective Studies,
pubmed-meshheading:11916624-Receptors, Cytoplasmic and Nuclear,
pubmed-meshheading:11916624-Transcription Factors
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Lack of association between peroxisome proliferator-activated receptor-gamma-2 gene variants and the occurrence of coronary heart disease in patients with diabetes mellitus.
|
|
pubmed:affiliation |
Third Medical Department, Leipzig University, Philipp-Rosenthal Strasse 27, D-04103 Leipzig, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
